These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 1177347)

  • 21. Azithromycin prophylaxis and treatment of murine toxoplasmosis.
    Tabbara KF; Hammouda E; Tawfik A; Al-Omar OM; Abu El-Asrar AM
    Saudi Med J; 2005 Mar; 26(3):393-7. PubMed ID: 15806206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of sulfadiazine and pyrimetamine for treatment of experimental toxoplasmosis with strains obtained from human cases of congenital disease in Brazil.
    Silva LA; Fernandes MD; Machado AS; Reis-Cunha JL; Bartholomeu DC; Almeida Vitor RW
    Exp Parasitol; 2019 Jul; 202():7-14. PubMed ID: 31077733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Efficacy of treatments in experimental toxoplasmosis].
    Tassignon MJ; Brihaye M; De Meuter F; Vercruysse A; Van Hoof F; De Wilde F
    Bull Soc Belge Ophtalmol; 1989; 230():59-72. PubMed ID: 2488436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of acute Toxoplasma gondii infections in mice with diclazuril or a combination of diclazuril and pyrimethamine.
    Lindsay DS; Rippey NS; Blagburn BL
    J Parasitol; 1995 Apr; 81(2):315-8. PubMed ID: 7707217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A clinical-parasitological monotherapy cure in the treatment of experimental infection by a highly virulent strain of Toxoplasma gondii.
    de Diego JA; Penin P; Arribas JR; Vázquez E; Vázquez JJ
    Folia Microbiol (Praha); 1996; 41(6):513-6. PubMed ID: 9131805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of trimethoprim and sulfamethoxazole on Toxoplasma gondii in vitro and in vivo.
    Grossman PL; Remington JS
    Am J Trop Med Hyg; 1979 May; 28(3):445-55. PubMed ID: 453442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enrofloxacin is able to control Toxoplasma gondii infection in both in vitro and in vivo experimental models.
    Barbosa BF; Gomes AO; Ferro EA; Napolitano DR; Mineo JR; Silva NM
    Vet Parasitol; 2012 Jun; 187(1-2):44-52. PubMed ID: 22281151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative effects of cotrimoxazole (trimethoprim-sulphamethoxazole) and spiramycin in pregnant mice infected with Toxoplasma gondii (Beverley strain).
    Nguyen BT; Stadtsbaeder S
    Br J Pharmacol; 1985 Jul; 85(3):713-6. PubMed ID: 3875381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Therapeutic future of trimethoprim-sulfamethoxazole in toxoplasmosis].
    Nguyen BT; Stadtsbaeder S
    Presse Med; 1983 Feb; 12(6):331-3. PubMed ID: 6221325
    [No Abstract]   [Full Text] [Related]  

  • 30. Chemotherapy of experimental toxoplasmosis with special reference to robenidine.
    Bakhtari SK; Jíra J
    Folia Parasitol (Praha); 1988; 35(3):193-8. PubMed ID: 2974008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparative activity of several antibiotics against Toxoplasma gondii in a mouse model].
    Rodríguez-Díaz JC; Martínez-Grueiro MM; Martínez-Fernández AR
    Enferm Infecc Microbiol Clin; 1993 Dec; 11(10):543-6. PubMed ID: 8142504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of trimethoprim and sulphamethoxazole as monotherapy or in combination in the management of toxoplasmosis in murine models.
    Dumas JL; Pizzolato G; Pechère JC
    Int J Antimicrob Agents; 1999 Sep; 13(1):35-9. PubMed ID: 10563403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective, randomized trial of trimethoprim/sulfamethoxazole vs. pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis: discussion.
    Holland GN
    Ophthalmology; 2005 Nov; 112(11):1882-4. PubMed ID: 16271316
    [No Abstract]   [Full Text] [Related]  

  • 34. Synergistic activity of azithromycin and pyrimethamine or sulfadiazine in acute experimental toxoplasmosis.
    Derouin F; Almadany R; Chau F; Rouveix B; Pocidalo JJ
    Antimicrob Agents Chemother; 1992 May; 36(5):997-1001. PubMed ID: 1324642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [New pathogens and mode of action of azithromycin: Toxoplasma gondii].
    Derouin F
    Pathol Biol (Paris); 1995 Jun; 43(6):561-4. PubMed ID: 8539083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparative study on the effect of some clinically used sulfanilamide derivatives against toxoplasmosis in the mouse].
    Vischer WA
    Zentralbl Bakteriol Orig A; 1973 Mar; 223(2):398-408. PubMed ID: 4145848
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparison of trimethoprim in combination with sulfadiazine or sulfamethoxazole in the treatment of respiratory infections.
    Varde AB; Gaitonde AM; Tilve GH; Kale VV; Satoskar RS
    J Postgrad Med; 1981 Jul; 27(3):159-62. PubMed ID: 7299704
    [No Abstract]   [Full Text] [Related]  

  • 38. Acute monosymptomatic aseptic meningitis caused by Toxoplasma gondii.
    Vukmirovits G; Juhász P; Jankó M; Tóth L
    Acta Paediatr Hung; 1985; 26(1):31-4. PubMed ID: 2580542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of deferoxamine alone and combined with pyrimethamine on acute toxoplasmosis in mice.
    Mahmoud MS
    J Egypt Soc Parasitol; 1999; 29(3):791-803. PubMed ID: 12561919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potent effect of trimetrexate, a lipid-soluble antifolate, on Toxoplasma gondii.
    Kovacs JA; Allegra CJ; Chabner BA; Swan JC; Drake J; Lunde M; Parrillo JE; Masur H
    J Infect Dis; 1987 May; 155(5):1027-32. PubMed ID: 2951446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.